Acadian Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Acadian Asset Management's ALT Position: Q2 2026 in Review
Acadian Asset Management sold out of Altimmune (ALT) in Q2 2026, closing a stake of 7,311 shares — an estimated $22K sold.
Acadian Asset Management first reported a position in ALT in Q4 2016 and held it in 12 quarters. The position peaked at $2.51M in Q4 2016. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Acadian Asset Management reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
- Acadian Asset Management sold 7,311 Altimmune shares in Q2 2026, an estimated $22K.
- Acadian Asset Management first reported a position in Altimmune in Q4 2016 and held it in 12 quarters.
- Acadian Asset Management's Altimmune position peaked at $2.51M in Q4 2016.
- 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.